Paul G Ambrose

Best Publications

• Pharmacokinetics-Pharmacodynamics of Antimicrobial Therapy: It's Not Just for Mice Anymore

  Paul G. Ambrose;Sujata M. Bhavnani;Christopher M. Rubino;Arnold Louie

  819
  Citations

• Voriconazole Therapeutic Drug Monitoring

  J. Smith;N. Safdar;V. Knasinski;W. Simmons

  504
  Citations

• Back to the Future: Using Aminoglycosides Again and How to Dose Them Optimally

  George L Drusano;Paul G Ambrose;Sujata M Bhavnani;Joseph S Bertino

  297
  Citations

• Pharmacodynamics of Fluoroquinolones against <i>Streptococcus pneumoniae</i> in Patients with Community-Acquired Respiratory Tract Infections

  Unknown

  297
  Citations

• Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis

  Unknown

  295
  Citations

• Extended-Spectrum β-Lactamases and Clinical Outcomes: Current Data

  Unknown

  275
  Citations

• Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective

  Johan W Mouton;Paul G Ambrose;Rafael Canton;George L Drusano

  250
  Citations

• Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations.

  Tawanda Gumbo;Arnold Louie;Weiguo Liu;David Brown

  195
  Citations

• Pharmacokinetic-Pharmacodynamic Considerations in the Design of Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia Studies: Look before You Leap!

  Paul G. Ambrose;Sujata M. Bhavnani;Evelyn J. Ellis-Grosse;George L. Drusano

  184
  Citations

• Background and rationale for revised clinical and laboratory standards institute interpretive criteria (Breakpoints) for Enterobacteriaceae and Pseudomonas aeruginosa: I. Cephalosporins and Aztreonam.

  Michael N Dudley;Paul G Ambrose;Sujata M Bhavnani;William A Craig

  183
  Citations

• The Pharmacokinetic and Pharmacodynamic Profile of Tigecycline

  Unknown

  183
  Citations

• Randomized Pharmacokinetic and Pharmacodynamic Comparison of Fluoroquinolones for Tuberculous Meningitis

  Guy E. Thwaites;Guy E. Thwaites;Sujata M. Bhavnani;Tran Thi Hong Chau;Jeffrey P. Hammel

  176
  Citations

• Use of Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Support Phase 2 and 3 Dosing Strategies for Doripenem

  Unknown

  158
  Citations

• Pharmacokinetics-Pharmacodynamics of Tazobactam in Combination with Piperacillin in an In Vitro Infection Model.

  Brian VanScoy;Rodrigo E. Mendes;Anthony M. Nicasio;Mariana Castanheira

  144
  Citations

• Pharmacodynamics in the study of drug resistance and establishing in vitro susceptibility breakpoints: ready for prime time.

  Unknown

  140
  Citations

• Pharmacokinetics-Pharmacodynamics of Cefepime and Piperacillin- Tazobactam against Escherichia coli and Klebsiella pneumoniae Strains Producing Extended-Spectrum β-Lactamases: Report from the ARREST Program

  P. G. Ambrose;S. M. Bhavnani;R. N. Jones

  140
  Citations

• Isoniazid's Bactericidal Activity Ceases because of the Emergence of Resistance, Not Depletion of Mycobacterium tuberculosis in the Log Phase of Growth

  Tawanda Gumbo;Arnold Louie;Weiguo Liu;Paul G. Ambrose

  139
  Citations

• CLINICAL USE OF THE FLUOROQUINOLONES

  Unknown

  132
  Citations

• Pharmacokinetic and Pharmacodynamic Evaluation of Liposomal Amikacin for Inhalation in Cystic Fibrosis Patients with Chronic Pseudomonal Infection

  Ólanrewaju O. Okusanya;Sujata M. Bhavnani;Jeffrey Hammel;Predrag Minic

  128
  Citations

• Effect of food and antacids on the pharmacokinetics of pirfenidone in older healthy adults.

  C.M. Rubino;S.M. Bhavnani;P.G. Ambrose;A. Forrest

  126
  Citations